Evidence map›Paper›PMID 41404476›Full record

ReviewNanoscale advances2026

Targeting brain tumours with precision: advances in magnetic nanoparticle therapy.

Subham Preetam, Muhammad Fazle Rabbee, Richa Mishra, Shailendra Thapliyal, Ravi Deshwal, Sarvesh Rustagi, Archana Dashmana, Rasiravathanahalli K Govindarajan, Sumira Malik

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Nanoscale advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Subham PreetamDepartment of Robotics and Mechatronics Engineering, Daegu Gyeongbuk Institute of Science and Technology (DGIST) Dalseong-gun Daegu 42988 Republic of Korea subhampreetam@dgist.ac.kr.ORCID https://orcid.org/0000-0002-5992-4609
Muhammad Fazle RabbeeDepartment of Biotechnology, Yeungnam University Gyeongsan Gyeongbuk 38541 Republic of Korea rabbi.biotech@gmail.com.
Richa MishraDepartment of Computer Engineering, Parul Institute of Engineering and Technology (PIET), Parul University Ta. Waghodia Vadodara Gujarat 391760 India richa.mishra31240@paruluniversity.ac.in.
Shailendra ThapliyalUttaranchal Institute of Technology, Uttaranchal University Dehradun 248007 India.ORCID https://orcid.org/0009-0002-6212-2057
Ravi DeshwalInstitute of Bioscience and Technology, Shri Ramswaroop Memorial University Lucknow-Deva Road Uttar Pradesh 225 003 India.
Sarvesh RustagiSchool of Agriculture, Dev Bhoomi Uttarakhand University Dehradun 248007 Uttarakhand India.ORCID https://orcid.org/0000-0002-1247-1040
Archana DashmanaHimalayan School of Biosciences, Swami Rama Himalayan University Dehradun Uttarakhand 248016 India archnadhasmana@srhu.edu.in.
Rasiravathanahalli K GovindarajanDepartment of Biotechnology, Karpagam Academy of Higher Education Coimbatore Tamil Nadu 641021 India.
Sumira MalikAmity Institute of Biotechnology, Amity University Jharkhand Ranchi 834002 India smalik@rnc.amity.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain cancer remains one of the most challenging malignancies due to the blood-brain barrier (BBB), limited drug penetration, and resistance to conventional therapies. Recent advancements in magnetic nanoparticles (MNPs) have opened new avenues for targeted and efficient brain cancer treatment. MNPs offer multifunctionality, including magnetic hyperthermia therapy, targeted drug delivery, and enhanced imaging

Identifiers

PMID41404476
PMCPMC12704653

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.